Pharmafile Logo
Pharmafocus logo
Advanced Search

chemotherapy

Showing 15 posts of 21 posts found.

lungs

European Commission approves combination chemotherapy for treatment of advanced EGFR-mutated non-small cell lung cancer in adult patients

August 27, 2024
Research and Development J&J, Oncology, chemotherapy, non-small cell lung cancer

Today, Janssen-Cilag International, part of Johnson & Johnson (J&J) has announced that the European Comission (EC) has approved a combined …

News

AstraZeneca’s Tagrisso approved in Japan for lung cancer treatment

June 25, 2024
Medical Communications AstraZeneca, Oncology, Tagrisso, chemotherapy, lung cancer

AstraZeneca has announced that Tagrisso (osimertinib) in combination with pemetrexed and platinum-based chemotherapy has been approved in Japan for the …

News

AstraZeneca’s Imfinzi approved in US for endometrial cancer treatment

June 17, 2024
Medical Communications AstraZeneca, Imfinzi, Oncology, chemotherapy, endometrial cancer

AstraZeneca has announced that the US Food and Drug Administration (FDA) has approved Imfinzi (durvalumab) in combination with carboplatin and …

News

Targeted chemotherapy to kill all solid tumours developed in preclinical research

August 3, 2023
Research and Development Cancer, Oncology, chemotherapy, pharmaceutical, tumour

Researchers from the City of Hope organisation in the US have released a study confirming the development of AOH1996, a …

News

AstraZeneca announces positive results from phase 3 trial for Tagrisso plus chemotherapy

May 17, 2023
Research and Development AstraZeneca, Cancer, Oncology, Tagrisso, chemotherapy

AstraZeneca has announced positive results from the FLAURA2 phase 3 trial which showed that Tagrisso (osimertinib), in combination with chemotherapy, …

News

Single cycle of chemo is just as effective as two in treating testicular cancer, study finds

January 3, 2020
Medical Communications Cancer, Men's Cancer, chemo, chemotherapy, testicular cancer

A new study shows that testicular cancer can be successfully treated with less rounds of chemotherapy. The recent study, published …

News
lilly_building_with_american_flag_web

Lilly’s Lartruvo/chemo combo surprises with Phase 3 failure in soft tissue carcinoma

January 21, 2019
Research and Development, Sales and Marketing Cancer, Eli Lilly, carcinoma, chemotherapy, pharma, trial failure

Eli Lilly has reluctantly pulled back the curtain on new Phase 3 data for its platelet-derived growth factor receptor alpha …

News

Roche’s Tecentriq+chemo combo shows first-line benefit in small cell lung cancer

September 26, 2018
Research and Development Cancer, Combo, Roche, chemotherapy, lung cancer, pharma, tecentriq

Roche has unveiled new Phase 3 data for its cancer immunotherapy Tecentriq (atezolizumab) in combination with carboplatin and etoposide chemotherapy …

News
White blood cells

CHMP recommend white blood cell growth stimulator biosimilar to EMA

July 30, 2018
Sales and Marketing Amgen, CHMP, EMA, Neulasta, biosimilar, chemotherapy, pegfilgrastim

The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of two separate …

News
convert-logo1

Convert secures €13.6m grant to develop targeted chemo for oxygen-deprived tumours

March 9, 2018
Medical Communications, Research and Development Belgium, Cancer, Convert pharma, chemotherapy, pharma

Belgium’s Convert Pharmaceuticals has secured a €13.6 million grant for initial development efforts on a new targeted chemotherapy drug which …

News
novartis_window

Novartis’ drug doubly effective as chemotherapy for treating lung cancer

December 8, 2016
NSCLC, Novartis, chemotherapy

Novartis have released that its drug, Zykadia, in Phase III trials, was twice as effective at slowing progression in advanced …

News
teva_copy

Teva’s drug to replace chemotherapy in acute leukaemia

November 21, 2016
Medical Communications, Sales and Marketing Teva, chemotherapy, first line, first-line, leukaemia

Teva Pharmaceutical announced that their drug Trisenox has been given approval from the European Commission to become the first line …

News
cq5dam

New drugs to utilise DNA damage response to kill cancer cells

July 26, 2016
Research and Development, Sales and Marketing AstraZeneca, Cancer, Wellcome Trust, chemotherapy, dna damage response, university of sussex

The University of Sussex is set to produce a portfolio of new cancer drugs which exploit our DNA damage response …

News
chemo-web

Midatech launch treatment to reduce chemo-induced vomiting in the US

April 11, 2016
Research and Development, Sales and Marketing chemotherapy, midatech, nausea, oncology, radiation, vomiting

Midatech Pharma (NASDAQ: MTP) has the full commercial launch of Zuplenz (ondansetron) in the US. The drug is an oral …

News
Avastin image

EU nod for Roche cancer drug and chemotherapy

April 8, 2015
Sales and Marketing Cancer, Roche, avastin, bevacizumab, cervical, chemotherapy, wet AMD

The European Commission has approved Roche’s Avastin in combination with standard chemotherapy for women with advanced cervical cancer.  Avastin (bevacizumab) …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026